Minor Ailments Pharmacology Flashcards
Decongestants: Used for? What receptor does it bind to? Mechanism of Action?
Topical (nasal, ophthalmic) and systemic decongestants are widely used in cough-cold preparations and in anti-allergy medications
Decongestants are α1 adrenergic receptor agonists that act in the nasal mucosa to produce vasoconstriction
Vasoconstriction decreases resistance to airflow and improves ventilation by decreasing the volume of the nasal mucosa and reduced delivery and secretion of fluids to the nasal mucosa
Ephedrine. What class does it belong to? What receptors does it bind to? What does it cause the release of?
Decongestant: Natural product, mixed-acting sympathomimetic drug
Directly stimulates α1-adrenergic receptors of respiratory mucosa causing vasoconstriction
Directly stimulates β-adrenergic receptors causing bronchial relaxation, increased heart rate and contractility
Enhances release of NE from sympathetic neurons
Pseudoephedrine: What receptors does it bind to? How does it compare to ephedrine?
Stereoisomer of ephedrine, but less potent than ephedrine in producing tachycardia, increasing blood pressure, and CNS stimulation
Directly stimulates α1-adrenergic receptors of nasal mucosa causing vasoconstriction;
Directly stimulates β-adrenergic receptors causing bronchial relaxation, increased heart rate and contractility
Phenylephrine: Class? Receptor?
Decongestant, and is a selective a1 adrenergic agonist
What is the onset of action for oral decongestants? And the adverse effects depends on?
Onset of action ~ 30 minutes
Adverse effects depend on the degree of α1 receptor selectivity
insomnia, tremor, irritability, nervousness, restlessness, dizziness, headache, tachycardia, palpitation, increased blood pressure (particularly in hypertensive patients
Topical nasal decongestants onset of action?
Onset of action – 5-10 minutes
Xylometazoline (Otrivin) 0.1%
Oxymetazoline (Dristan) 0.5%
What are these? Dosing? And are these short or long acting ?
Topical nasal decongestants, long-acting, and dosing is 2-3 sprays in each nostril q10-12 up to BID.
Phenylephrine Nasal. Dosing? Type of medication?
Short acting topical nasal decongestant.
Dose will be 2-3 sprays in each nostril q4h
Antitussives: Examples, MOA
Codeine and dextromethorphan
MOA: act centrally on medulla to increase cough threshold
Image: See the different parts of the medulla?
Opioid Antitussives
Codeine is both an opiate and an opioid
Acts on opioid receptors in the medullary cough centre
May also have additional peripheral action on cough receptors in proximal airways
Note – codeine itself has antitussive properties (does not require metabolism to morphine, which is needed for its full analgesic action)
Little evidence for effectiveness at OTC doses ADRs: sedation, constipation
Dextromethorphan. Does it have analgesic or euphoric properties? Where does it Act? Side effects compared to codeine?
No analgesic or euphoric properties
Does not act through opioid receptors
Acts centrally to elevate threshold for coughing
Produces fewer subjective and GI side effects compared to codeine
Dextromethorphan Metabolism: What happens if its taken in poor metabolizers or with 2D6 inhibitors?
What happens if you take it with MAOIs?
Metabolized by CYP 2D6, increased CNS effects in poor metabolizers/drug interactions with 2D6 inhibitors
Occasional dizziness, drowsiness, nausea
Risk of serotonin syndrome with MAOIs (contraindicated, blocks serotonin reuptake)
Expectorants
- Compounds that helps bring mucous and other materials from the bronchi
- Guaifenesin is an expectorant found in many cough-cold products
- Thought to act as an expectorant by stimulating respiratory tract secretions, thereby increasing respiratory fluid volumes and decreasing mucous viscosity
- May also promote mucociliary activity
- Evidence for efficacy is very limited, but so is the evidence for adverse effects, no known drug interactions
Histamine
Stored in which cells, tissues?
Physiological roles?
Primary storage site in tissues is in mast cells
Tissues with large numbers of mast cells include skin, bronchial mucosa, intestinal mucosa, also stored in basophils
Physiological roles in early phases of allergic reactions, GI acid secretion, immune system function, and sleep-wake cycles
Histamine in Allergic Responses
Mast cells after interacting with antigen through IgE antibodies= Ip3 is increased= increases intracellular calcium, this calcium causes exocytosis of histamine from secretory granules .
Other allergic mediators like leukotrienes also secreted
Mast cell with signaling pathways. Physically stimulated, or antigens, or compliment pathway during immune response. Drugs can also promote or inhibit release.
Beta adrenergic agents )epinephrine, isoproterenol) can inhibit, as can prostaglandins, and Ach can promote the release (but can be blocked by atropine).
Once activated, Histamine can bind to:
H1, H2, H3, H4
All are GPCRs
H1 receptors:
H1 receptors:
Distributed widely in CNS** and **periphery, particularly on smooth muscle and endothelial cells
Many of the common effects of histamine are due to activation of H<u>1 </u>receptors (itching, stimulation of nasal secretion, sedation associated with antihistamines, etc.)
H2 receptors:
Distributed in gastric parietal cells (involved in gastric acid secretion), cardiac muscle, mast cells, CNS